Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

520 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply.
Ben-Shabat N, Shabat A, Watad A, Kridin K, Bragazzi NL, McGonagle D, Comaneshter D, Cohen AD, Amital H. Ben-Shabat N, et al. Among authors: mcgonagle d. Arthritis Care Res (Hoboken). 2022 Dec;74(12):2121-2122. doi: 10.1002/acr.24771. Epub 2022 Aug 23. Arthritis Care Res (Hoboken). 2022. PMID: 34437772 No abstract available.
Enthesitis: Much More Than Focal Insertion Point Inflammation.
Watad A, Cuthbert RJ, Amital H, McGonagle D. Watad A, et al. Among authors: mcgonagle d. Curr Rheumatol Rep. 2018 May 30;20(7):41. doi: 10.1007/s11926-018-0751-3. Curr Rheumatol Rep. 2018. PMID: 29846815 Free PMC article. Review.
Immunogenicity, safety and tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus patients: An evidence-informed and PRISMA compliant systematic review and meta-analysis.
Adawi M, Bragazzi NL, McGonagle D, Watad S, Mahroum N, Damiani G, Conic R, Bridgewood C, Mahagna H, Giacomelli L, Eggenhöffner R, Mahamid M, Pigatto PDM, Amital H, Watad A. Adawi M, et al. Among authors: mcgonagle d. Autoimmun Rev. 2019 Jan;18(1):73-92. doi: 10.1016/j.autrev.2018.08.002. Epub 2018 Nov 5. Autoimmun Rev. 2019. PMID: 30408581 Free article.
Regression of Peripheral Subclinical Enthesopathy in Therapy-Naive Patients Treated With Ustekinumab for Moderate-to-Severe Chronic Plaque Psoriasis: A Fifty-Two-Week, Prospective, Open-Label Feasibility Study.
Savage L, Goodfield M, Horton L, Watad A, Hensor E, Emery P, Wakefield R, Wittmann M, McGonagle D. Savage L, et al. Among authors: mcgonagle d. Arthritis Rheumatol. 2019 Apr;71(4):626-631. doi: 10.1002/art.40778. Epub 2019 Mar 4. Arthritis Rheumatol. 2019. PMID: 30468001 Free article. Clinical Trial.
520 results